Changes in response to, and production of, transforming growth factor type β during neoplastic progression in cultured rat tracheal epithelial cells
- 1 June 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 10 (6) , 973-980
- https://doi.org/10.1093/carcin/10.6.973
Abstract
As rat tracheal epithelial cells progress from a normal to a neoplastic phenotype there are systematic changes in their ability to produce and activate latent transforming growth factor type β (TGF-β) as well as systematic changes in their response to this growth factor. Using a TGF-β radioreceptor binding competition assay it was found that normal proliferating rat tracheal cells in early primary culture produced latent TGF-β. With the emergence of terminally differentiated cell populations active TGF-β was also detected in the conditioned medium. When normal cells were cultured under conditions allowing for condinued proliferation, no active TGF-β was detected in the conditioned medium. Colonies of proliferating epithelial cells in 4–6 week primary cultures or subculturable trachelial cell lines did not produce detectable levels of active or latent growth factor. With neoplastic progression there was likewise a change in response to active TGF-β. Normal tracheal cells in primary culture were highly sensitive to growth-factor-induced decreases in thymidine uptake as well as to the induction of terminal differentiation. Proliferating epithelial cells in late (4–6 week) primary cultures and preneoplastic, subculturable cell lines were often as sensitive as normal cells to the growth factor-induced decline in thymidine uptake. None of these altered populations, however, was induced to differentiate (to form cornified, cross-linked envelopes) in the presence of TGF-β.Keywords
This publication has 16 references indexed in Scilit:
- ROLE OF SPONTANEOUS TRANSFORMATION IN CARCINOGENESIS - DEVELOPMENT OF PRENEOPLASTIC RAT TRACHEAL EPITHELIAL-CELLS AT A CONSTANT RATE1986
- Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.Proceedings of the National Academy of Sciences, 1986
- INHIBITION OF CARCINOGEN-ALTERED RAT TRACHEAL EPITHELIAL-CELLS BY NORMAL EPITHELIAL CELL-CONDITIONED MEDIUM1986
- Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.Proceedings of the National Academy of Sciences, 1984
- Normal embryo fibroblasts release transforming growth factors in a latent formJournal of Cellular Physiology, 1984
- Serum contains a platelet-derived transforming growth factor.Proceedings of the National Academy of Sciences, 1982
- New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.Proceedings of the National Academy of Sciences, 1981
- ONCOGENIC TRANSFORMATION IN EPITHELIAL-CELL LINES DERIVED FROM TRACHEAL EXPLANTS EXPOSED INVITRO TO N-METHYL-N'-NITRO-N-NITROSOGUANIDINE1979
- DYNAMICS OF NEOPLASTIC DEVELOPMENT IN CARCINOGEN-EXPOSED TRACHEAL MUCOSA1979
- Differentiation of the epidermal keratinocyte in cell culture: Formation of the cornified envelopeCell, 1976